 | | Desvenlafaxine | | Systematic (IUPAC) name | 4-[2-dimethylamino-1-(1-hydroxycyclohexyl) ethyl]phenol | | Identifiers | | CAS number | 93413-62-8 | | ATC code | ? | | PubChem | 125017 | | Chemical data | | Formula | C16H25NO2 | | Mol. mass | 263.375 g/mol | | Synonyms | O-desmethylvenlafaxine Norvenlafaxine | | Pharmacokinetic data | | Bioavailability | ? | | Metabolism | ? | | Half life | ? | | Excretion | ? | | Therapeutic considerations | | Pregnancy cat. | ? IUPAC nomenclature is a system of naming chemical compounds and of describing the science of chemistry in general. ...
CAS registry numbers are unique numerical identifiers for chemical compounds, polymers, biological sequences, mixtures and alloys. ...
The Anatomical Therapeutic Chemical Classification System is used for the classification of drugs. ...
PubChem is a database of chemical molecules. ...
A chemical formula (also called molecular formula) is a concise way of expressing information about the atoms that constitute a particular chemical compound. ...
General Name, Symbol, Number carbon, C, 6 Chemical series nonmetals Group, Period, Block 14, 2, p Appearance black (graphite) colorless (diamond) Atomic mass 12. ...
General Name, Symbol, Number hydrogen, H, 1 Chemical series nonmetals Group, Period, Block 1, 1, s Appearance colorless Atomic mass 1. ...
General Name, Symbol, Number nitrogen, N, 7 Chemical series nonmetals Group, Period, Block 15, 2, p Appearance colorless gas Atomic mass 14. ...
General Name, Symbol, Number oxygen, O, 8 Chemical series nonmetals, chalcogens Group, Period, Block 16, 2, p Appearance colorless (gas) very pale blue (liquid) Standard atomic weight 15. ...
The molecular mass (abbreviated MM) of a substance, formerly also called molecular weight and abbreviated as MW, is the mass of one molecule of that substance, relative to the unified atomic mass unit u (equal to 1/12 the mass of one atom of carbon-12). ...
Look up Synonym in Wiktionary, the free dictionary. ...
In pharmacology, bioavailability is used to describe the fraction of an administered dose of medication that reaches the systemic circulation, one of the principal pharmacokinetic properties of drugs. ...
Drug metabolism is the metabolism of drugs, their biochemical modification or degradation, usually through specialized enzymatic systems. ...
It has been suggested that Effective half-life be merged into this article or section. ...
Excretion is the process of eliminating waste products of metabolism and other materials that are of no use. ...
The pregnancy category of a pharmaceutical agent is an assessment of the risk of fetal injury due to the pharmaceutical, if it is used as directed by the mother during pregnancy. ...
| | Legal status | | | Routes | ? | Desvenlafaxine succinate, marketed under the name Pristiq, is an antidepressant of the serotonin-norepinephrine reuptake inhibitor class from Wyeth. It is a metabolite of venlafaxine (Effexor). The regulation of therapeutic goods, that is drugs and therapeutic devices, varies by jurisdiction. ...
In pharmacology and toxicology, a route of administration is the path by which a drug, fluid, poison or other substance is brought into contact with the body 1. ...
Serotonin Norepinephrine Serotonin-norepinephrine reuptake inhibitors (SNRIs) are a class of antidepressant used in the treatment of clinical depression and other affective disorders. ...
Wyeth, formerly known as American Home Products, is one of the largest pharmaceutical companies in the world. ...
Venlafaxine hydrochloride is a prescription antidepressant first introduced by Wyeth in 1993. ...
Approval status
It has completed Phase III trials and is waiting for approval by the U.S. Food and Drug Administration. Wyeth announced on January 23 that they received an "approvable" letter from the FDA for venlafaxine. Final approval to sell the drug is contingent on a number of things, including: In medicine, a clinical trial (synonyms: clinical studies, research protocols, medical research) is the application of the scientific method to human health. ...
The Food and Drug Administration (FDA) is an agency of the United States Department of Health and Human Services and is responsible for regulating food (humans and animal), dietary supplements, drugs (human and animal), cosmetics, medical devices (human and animal) and radiation emitting devices (including non-medical devices), biologics, and...
- a satisfactory FDA inspection of Wyeth's Guayama, Puerto Rico facility, where the drug is to be manufactured;
- several post-marketing commitments;
- clarity by Wyeth around the company's product education plan for physicians and patients;
- approval of desvenlafaxine's proprietary name, Pristiq.[1]
Wyeth expects the drug to be approved for sales in early 2007.[2]
References - ^ (January 23, 2007). Wyeth Receives Approvable Letter From FDA For Pristiq (Desvenlafaxine Succinate) For The Treatment Of Major Depressive Disorder. Press release. Retrieved on 2007-04-04.
- ^ Wyeth (August 29, 2006). Re-formatted Data Submission Results in Extension of FDA Review for Desvenlafaxine Succinate. Press release. Retrieved on 2007-04-04.
| Antidepressants (ATC N06A) | | Monoamine oxidase inhibitors (MAOI) | Harmaline, Iproniazid, Isocarboxazid, Nialamide, Pargyline, Phenelzine, Selegiline, Toloxatone, Tranylcypromine RIMAs: Brofaromine, Moclobemide | | Dopamine reuptake inhibitor (DARI) | Amineptine, Phenmetrazine, Vanoxerine | | Norepinephrine-dopamine reuptake inhibitors (NDRI) | Bupropion | | Norepinephrine reuptake inhibitor (NRI) or (NARI) | Atomoxetine, Maprotiline, Reboxetine, Viloxazine | | Serotonin-norepinephrine reuptake inhibitor (SNRI) | Desvenlafaxine, Duloxetine, Milnacipran, Nefazodone, Venlafaxine | | Selective serotonin reuptake inhibitor (SSRI) | Alaproclate, Citalopram, Escitalopram, Etoperidone, Fluoxetine, Fluvoxamine, Paroxetine, Sertraline, Zimelidine | | Selective serotonin reuptake enhancer (SSRE) | Tianeptine | | Noradrenergic and specific serotonergic antidepressant (NaSSA) | Mirtazapine | | Tricyclic antidepressants (TCA) | Amitriptyline, Amoxapine, Butriptyline, Clomipramine, Desipramine, Dibenzepin, Dothiepin, Doxepin, Imipramine, Iprindole, Lofepramine, Melitracen, Nortriptyline, Opipramol, Protriptyline, Trimipramine | | Tetracyclic antidepressants | Maprotiline, Mianserin, Nefazodone, Trazodone | |